News
Present your organisation on a global scale with the Health~Holland Guide
The Health~Holland Guide (HHG) has already had a major impact on the international healthcare sector for fives years in a row. The HHG is a foreign-oriented guide in which Dutch organisations, active in the Dutch Top Sector Life Sciences & Health, are presented worldwide.
Lessons from successful scientific entrepreneurs for biotech start-ups
The biotechnology landscape is complex and defining a business strategy that will lead to success is challenging. Meike Sloet van Oldruitenborgh wrote an article about it, as part of her Research internship at Catalyze. The article reveals the main conclusions of a survey amongst scientific entrepreneurs in The Netherlands wherein nine successful entrepreneurs shared their inside business knowledge to empower the Dutch biotech sector.
Xplore US 2017: Your bridge to the US market
This contest is your ticket to Boston to explore the US market. Provided you are an SME or Scale-up with an innovative product or service and have what it takes to become successful in the US. Ten winning companies will take part in a ten-day accelerator programme in the US by MIT spin-off kTeams.
Weekend of Science
Voor het zesde achtereenvolgende jaar vindt op 7 en 8 oktober het Weekend van de Wetenschap plaats. Met dit wetenschapsfestival, georganiseerd in opdracht van het Ministerie van OCW, worden de wetenschap en het wetenschappelijk onderzoek in de schijnwerpers gezet.
Health~Holland meet~up brings care and innovation together
Zoals jullie weten staat de gezondheidszorg voor de grote uitdaging om de kwaliteit, toegankelijkheid, betaalbaarheid en de groeiende zorgvraag het hoofd te bieden. Oplossingen hiervoor kunnen deels gevonden worden in digitale innovaties.
ZCube announces the second edition of Open Accelerator: an international call for ideas for life sciences startups
ZCube, Research Venture of the pharmaceutical group Zambon, launches the second edition of Open Accelerator, a fast track acceleration program for life science start-up projects.
New Phase 2 study with filgotinib in non-infectious uveitis
Galapagos NV (Euronext & NASDAQ: GLPG) announces a new Phase 2 study investigating filgotinib in non-infectious uveitis, being led by filgotinib collaboration partner Gilead Sciences, Inc.
Medical Delta Ready for the next phase
On June 27th the Medical Delta Event event entitled 'We add value – Value based healthcare & the role of technology' took place. A great line-up of speakers took their audience from undeniable facts and figures along razor-sharp quotes to conclusions inspiring anything from worry to pride. What deserves to be remembered is definitely this: all ingredients for success are there. “So let's roll up our sleeves and continue on this journey together.”
Trend scenario VTV-2018 identifies societal challenges for the future
Als historische trends zich onveranderd door zetten, veroorzaakt dementie in 2040 de meeste ziektelast en is het de belangrijkste doodsoorzaak. Het aantal mensen dat overlijdt als gevolg van dementie zal dan toenemen van 14.000 in 2015 tot bijna 40.000 in 2040. Dit is één van de belangrijkste bevindingen van het Trendscenario van de VTV-2018. Het Trendscenario laat zien hoe onze volksgezondheid er in 2040 uit zou kunnen zien als er vanaf nu niets meer zou veranderen. Zo kunnen maatschappelijke opgaven voor de toekomst geïdentificeerd worden.
Re-opening Innovation Performance Contracts (IPC)
Collaborating SMEs in the same region or industry that together execute an innovation trajectory can apply for a grant between September 21 and October 5 via the Innovation Performance Contracts (IPC).